Mitchell Levine

Mitchell Levine

Chairman at IMMUNOPRECISE ANTIBODIES LTD.

Net worth: 30 400 $ as of 30/03/2024

Finance
Health Technology
Consumer Services

Profile

Mitchell Stuart Levine is the founder of Enable Global Capital LLC, which was founded in 2002.
He held the title of Managing Member & Chief Compliance Officer at Enable Global Capital LLC from 2011 to 2017.
Mr. Levine is currently the Chairman & Chief Executive Officer at Smart Health Diagnostics Co. since 2022 and the Chairman at ImmunoPrecise Antibodies Ltd.
since 2023.
Mr. Levine has held former positions as Principal at Bear, Stearns & Co., Inc., Principal at Lehman Brothers Distressed Structured Credit Capital Partners, Principal at The Shemano Group, Inc., Managing Partner at Cove Capital Advisors, Inc., and Chief Financial Officer at OncoCyte Corp.
from 2017 to 2022.
Mr. Levine obtained his undergraduate degree from the University of California, Davis.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
20/03/2024 20,000 ( 0.08% ) 30 400 $ 30/03/2024

Mitchell Levine active positions

CompaniesPositionStart
IMMUNOPRECISE ANTIBODIES LTD. Chairman 26/11/2023
Chief Executive Officer 31/10/2022
All active positions of Mitchell Levine

Former positions of Mitchell Levine

CompaniesPositionEnd
Founder 31/12/2016
Cove Capital Advisors, Inc. Corporate Officer/Principal -
ONCOCYTE CORPORATION Director of Finance/CFO 31/05/2022
Lehman Brothers Distressed Structured Credit Capital Partners Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Mitchell Levine's experience

Training of Mitchell Levine

University of California, Davis Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mitchell Levine's experience

Connections

18

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
ONCOCYTE CORPORATION

Health Technology

IMMUNOPRECISE ANTIBODIES LTD.

Health Technology

Private companies6

Finance

Lehman Brothers Distressed Structured Credit Capital Partners

Finance

Finance

Cove Capital Advisors, Inc.

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Mitchell Levine